Technology | March 25, 2011

FDA Clears Gamma Ray Stereotactic Neurosurgery System

March 25, 2011 – The U.S. Food and Drug Administration (FDA) has cleared a gamma ray neurosurgery system. The Infini system, from Masep Infini, reduces procedure times and can increase patient throughput.

It features independent beam switch control with programmable arcs, automated collimator exchange and three-dimensional patient positioning and the company’s Rotary Focusing technology. Independent beam switch control with programmable arcs allows for fine-tuning of dose distributions to address even the most challenging cases. Automated collimator exchange and three-dimensional patient positioning allow radiosurgery to be conducted without the need to interrupt procedures to manually exchange collimators or re-position patients. Treatment can also be initiated by the simple push of a button.

The patented Rotary Focusing technology provides customers with reduced system acquisition and maintenance costs. It allows the system to operate with fewer cobalt sources than comparable fixed cobalt source systems without compromising total activity levels.

"The Infini is a welcome addition to the field of gamma ray radiosurgery," said Edward Laws, M.D., director of the Pituitary and Neuroendocrine Center at Brigham and Women's Hospital in Boston. "For patients with indications for gamma ray radiosurgery and for hospitals and clinics who provide it, there was really only one option available and not all healthcare systems could meet the acquisition and replacement costs of this type of equipment. Masep Infini's new system meets the technological requirements neurosurgeons demand but in an affordable, practical package."

Stereotactic gamma ray neurosurgery focuses radiation on specific areas of the brain to treat tumors and lesions. The head is held stationary using special headgear. The patient is then positioned and re-positioned inside the system during the treatment, which is painless and silent. The surgery does not require an incision, and is typically an outpatient procedure.

For more information: www.masepinfini.com

Related Content

Insightec Announces Expanded Reach of MR-Guided Focused Ultrasound
News | Focused Ultrasound Therapy | August 22, 2017
Insightec announced recently that worldwide adoption of magnetic resonance (MR)-guided focused ultrasound continues to...
UCLA Study Offers Roadmap to Personalized Therapies for Sarcoma
News | Oncology Diagnostics | August 22, 2017
A new UCLA study is the first to identify patient and tumor characteristics that predict the successful creation of...
Sponsored Content | Videos | Information Technology | August 22, 2017
Melissa Martin, MS, president of the American Association of Physicists in Medicine (AAPM), discusses her vision of t
Sponsored Content | Videos | Proton Therapy | August 21, 2017
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the cl
Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Overlay Init